GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Chaoju Eye Care Holdings Ltd (HKSE:02219) » Definitions » Net Income

Chaoju Eye Care Holdings (HKSE:02219) Net Income : HK$209 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Chaoju Eye Care Holdings Net Income?

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Chaoju Eye Care Holdings's Net Income for the six months ended in Dec. 2024 was HK$63 Mil. Its Net Income for the trailing twelve months (TTM) ended in Dec. 2024 was HK$209 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. Chaoju Eye Care Holdings's Earnings per Share (Diluted) for the six months ended in Dec. 2024 was HK$0.09.


Chaoju Eye Care Holdings Net Income Historical Data

The historical data trend for Chaoju Eye Care Holdings's Net Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chaoju Eye Care Holdings Net Income Chart

Chaoju Eye Care Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income
Get a 7-Day Free Trial 147.16 198.06 209.67 250.38 208.28

Chaoju Eye Care Holdings Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 93.98 164.74 85.64 146.90 62.59

Chaoju Eye Care Holdings Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

Chaoju Eye Care Holdings's Net Income for the fiscal year that ended in Dec. 2024 is calculated as

Net Income(A: Dec. 2024 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=280.502+-81.691+0+9.466
=208

Chaoju Eye Care Holdings's Net Income for the quarter that ended in Dec. 2024 is calculated as

Net Income(Q: Dec. 2024 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=88.705+-32.557+0+6.442
=63

Net Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$209 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chaoju Eye Care Holdings  (HKSE:02219) Net Income Explanation

Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

Chaoju Eye Care Holdings's Earnings per Share (Diluted) (EPS) for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Chaoju Eye Care Holdings Net Income Related Terms

Thank you for viewing the detailed overview of Chaoju Eye Care Holdings's Net Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Chaoju Eye Care Holdings Business Description

Traded in Other Exchanges
N/A
Address
No. 14 Yard, West 3rd Ring South Road, Block A, Shouke Building, 24th Floor, East Zone, Fengtai District, Beijing, CHN
Chaoju Eye Care Holdings Ltd is a ophthalmic medical service group in North China engaged in engaged in the provision of in-patient services, out-patient services and sales of optical products. The company generate revenue from consumer ophthalmic services and basic ophthalmic services. The consumer ophthalmic services include treatments and prevention of various types of ophthalmic disorders, including refractive correction, myopia control and provision of optical products and services. The basic ophthalmic services include treatments of a wide range of common eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases and pediatric eye diseases.
Executives
Zhang Junfeng 2103 Interests held jointly with another person
Zhang Xiaoli 2103 Interests held jointly with another person
Zhang Bozhou 2103 Interests held jointly with another person
Areo Holdings Limited 2201 Interest of corporation controlled by you
Li Gabriel 2201 Interest of corporation controlled by you
Lam Lai Ming 2201 Interest of corporation controlled by you
Orchid Asia Vii, L.p. 2201 Interest of corporation controlled by you
Orchid Asia Vii Gp, Limited 2201 Interest of corporation controlled by you
Orchid Asia V Group, Limited 2201 Interest of corporation controlled by you
Orchid Asia V Group Management, Limited 2201 Interest of corporation controlled by you
Oavii Holdings, L.p. 2201 Interest of corporation controlled by you
Orchid Asia Vii Global Investment Limited 2101 Beneficial owner
Wang Stephen Hui 2201 Interest of corporation controlled by you
Xia Men Chao Xi Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Zhang Wenwen 2201 Interest of corporation controlled by you

Chaoju Eye Care Holdings Headlines

No Headlines